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ARTICLE HIGHLIGHTS    15 
 16 
Type of Research: Multi-center cross sectional cohort 17 
study of experiences with central venous access line 18 
teams during the COVID-19 pandemic. 19 
 20 
Key Findings: Participants from 60 hospitals in 13 21 
countries contributed data.  75% of line teams included a 22 
vascular surgery attending physician. 2,657 central 23 
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venous lines were placed at 20 of the participating sites 1 
with 11 (0.41%) iatrogenic access complications 2 
associated with procedures performed by the line team.   3 
 4 
Take home Message: Implementation of a dedicated 5 
central venous access line team during health care 6 
emergencies, with staffing by physicians with central 7 
venous access expertise, a dedicated line cart, specific 8 
anatomic sites for different venous access needs,  and a 9 
method to track complications, can improve outcomes 10 





Table of Contents Summary   16 
 17 
Implementation of dedicated central venous access line teams during health care emergencies, 18 
with staffing by physicians with central venous access expertise, a dedicated line cart, 19 
recommended sites for access, and a method to track complications, can improve access delivery 20 




Introduction: During the COVID-19 pandemic, central venous access line teams were 2 
implemented at many hospitals throughout the world to provide access for critically ill patients. 3 
The objective of this study was to describe the structure, practice patterns and outcomes of these 4 
vascular access teams during the COVID-19 pandemic.  5 
Methods: We conducted a cross sectional, self-reported study of central venous access line teams 6 
in hospitals afflicted with the COVID-19 pandemic. In order to participate in the study, hospitals 7 
were required to meet one of the following criteria: a) development of a formal plan for a central 8 
venous access line team during the pandemic, b) implementation of a central venous access line 9 
team during the pandemic, c) placement of central venous access by a designated practice group 10 
during the pandemic as part of routine clinical practice, or d) management of an iatrogenic 11 
complication related to central venous access in a patient with COVID-19.   12 
Results: Participants from 60 hospitals in 13 countries contributed data to the study. Central 13 
venous line teams were most commonly composed of vascular surgery and general surgery 14 
attending physicians and trainees. Twenty sites had 2,657 lines placed by their central venous 15 
access line team or designated practice group. During that time, there were 11 (0.4%) iatrogenic 16 
complications associated with central venous access procedures performed by the line team or 17 
group at those 20 sites. Triple lumen catheters, Cordis® catheters and non-tunneled hemodialysis 18 
catheters were the most common types of central venous lines placed by the teams. Eight (14%) 19 
sites reported experience placing central venous lines in prone, ventilated patients with COVID-20 
19. A dedicated line cart was used by 35 (59%) of hospitals.  Less than 50% (24, 41%) of the 21 
participating sites reported managing thrombosed central lines in COVID-patients. Twenty-three 22 
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of the sites managed 48 iatrogenic complications in patients with COVID-19 (including 1 
complications caused by providers outside of the line team or designated practice group).  2 
Conclusions: Implementation of a dedicated central venous access line team during a pandemic 3 
or other healthcare crisis is a way by which physicians trained in central venous access can 4 
contribute their expertise to a stressed healthcare system. A line team composed of physicians 5 
with vascular skill sets provides relief to resource-constrained ICU, ward, and emergency 6 
medicine teams with a low rate of iatrogenic complications relative to historical reports. We 7 
recommend that a plan for central venous access line team implementation be in place for future 8 
healthcare crises. 9 
 10 
 11 




The novel coronavirus, SARS-CoV-2, has caused 7,293,307 cases of Coronavirus 2 
Disease 2019 (COVID-19) worldwide (as of June 10, 2020) and 413,126 deaths. Of those cases, 3 
1,990,112 have been in the United States with 112,441 associated deaths between February 6, 4 
2020 and June 10, 20201. Approximately 5-10% of patients with COVID-19 require admission to 5 
the intensive care unit and mechanical ventilation2-3. In these critically ill patients, the rates of 6 
septic shock and acute kidney injury are 20% and 15%, respectively4-5. As a result, these patients 7 
often require central venous access for the infusion of vasoactive agents and/or hemodialysis.  8 
In the COVID-19 crisis, overburdened health care systems throughout the world have had 9 
to address the need to provide central venous access for the unprecedented dramatic influx of 10 
critically ill patients, particularly during the surge period of the pandemic.  As a result, the 11 
procedure of placing central venous access, which is normally a routine occurrence in critical 12 
care units, has created unique challenges during the COVID-19 pandemic given the limited 13 
providers available to manage the extraordinary increase in critically ill patients. The limited 14 
resources may lead to central venous access procedures being performed by less experienced 15 
and/or overworked physicians, which results in an increased rate of serious complications6. 16 
Furthermore, central venous access procedures can result in physicians being occupied for a 17 
prolonged period by a single patient while the issues of other acutely ill patients are not being 18 
addressed. In the case of a COVID-19 positive patient, the central venous access procedure 19 
includes not only the time required to perform the procedure, but also the additional time 20 
required to don and doff the added personal protective equipment required.  21 
11 
 
During the COVID-19 pandemic, central venous access line teams have been developed 1 
at many hospitals throughout the world to handle the access needs of all patients in the hospital, 2 
freeing physicians with less experience in central venous access and those who are overburdened 3 
by acute and critical demands to focus on management of other patients requiring their attention7-4 
8
. The teams often consist of vascular surgeons, general surgeons, interventional radiologists, 5 
anesthesiologists, intensivists, and interventional cardiologists who have been trained and have 6 
extensive experience in central venous access, as well as experience identifying and managing 7 
the complications associated with central venous access procedures9-10. For example, to meet the 8 
increased demand for critical care providers at the University of Massachusetts, vascular 9 
surgeons formed a “Surgical Workforce Access Team (SWAT)” in order to best leverage the 10 
skillsets of vascular surgery division members and provide the best service to the hospital and to 11 
their colleagues7. At Mount Sinai Hospital in New York, physicians recognized a dramatic 12 
increase in the rate of central line complications and the resulting urgent vascular interventions. 13 
In response, the vascular surgeons created a line team8. 14 
While central line teams and protocols for line placement and management have been 15 
described in the past, those efforts have been focused on reducing central line-associated 16 
bloodstream infections rather than addressing a pressing need during a healthcare disaster11-13. 17 
Within the context of early isolated single-institution reports, we sought to provide a multi-18 
institutional experience of line teams during the pandemic. The objective of this study was to 19 
describe the structure, practice patterns, and outcomes of these line teams on central venous 20 




We conducted a cross-sectional, self-reported study of structured central venous access 1 
line teams and the physician groups providing central venous access in hospitals afflicted by the 2 
COVID-19 pandemic. In order to participate in the study, hospitals were required to meet one of 3 
the following criteria: a) development of a formal plan for a central venous access line team 4 
during the pandemic, b) implementation of a central venous access line team during the 5 
pandemic, c) placement of central venous access by a designated practice group during the 6 
pandemic as part of routine clinical practice, or d) management of an iatrogenic complication 7 
related to central venous access in a patient with COVID-19 8 
This study was a collaborative effort between the Vascular Low Frequency Disease 9 
Consortium (VLFDC) and the Vascular Surgery COVID-19 Collaborative (VASCC). The 10 
VLFDC is a multi-institutional collaboration, initiated 20 years ago, and designed to investigate 11 
uncommon vascular diseases14. The VASCC was established on March 2, 2020 to study the 12 
impact of the ongoing COVID-19 pandemic on vascular surgical care15, using an international 13 
registry.  14 
The Institutional Review Board of the University of California Los Angeles (UCLA) 15 
deemed this study protocol exempt as a quality improvement project. 16 
Database development  17 
The primary investigators (KW, TC, DJ, DR) initially developed the registry data 18 
elements by determining factors important to the structure and function of central venous access 19 
line teams’ experience of line placement during the pandemic, as well as iatrogenic 20 
complications associated with line placement. The draft registry was reviewed by a group of 21 
physician investigators with central venous line placement expertise and revised in an iterative 22 
13 
 
fashion until no further modifications were recommended by the group. This established the final 1 
standardized dataset for collection that constitutes the basis of this study.  2 
Data collection 3 
The study was disseminated through the VLFDC and VASCC electronic mailing lists and 4 
social media. Study data were collected and managed using REDCap (Research Electronic Data 5 
Capture), a web-based data collection mechanism designed for research16. Data entry into the 6 
registry opened on April 22, 2020 and closed on May 4, 2020. Study participants were required 7 
to record responses to all items in the database. Participants were contacted via electronic mail 8 
by the UCLA vascular research center for clarification of any discrepancies in the submitted data 9 
and missing data.   10 
Participants were required to enter their hospital characteristics, utilization of central 11 
venous access line teams during the pandemic, types of patients and locations in which the line 12 
team services were offered, team composition, team availability, criteria for activation and 13 
termination of their services, and anatomic sites used for access. Each institution was asked to 14 
provide details regarding any iatrogenic complications associated with central venous line 15 
placement, and if available, the total number of central venous access procedures performed 16 
during the time that the line team or designated practice group placing central lines was in place. 17 
Each institution was also given the opportunity to provide insight regarding successful 18 





             Participants from 60 hospitals in 13 countries contributed data to the study 1 
(Appendix A). Fifty-eight of the hospitals had plans in place for a central venous access line 2 
team, had implemented the line team, or had a designated practice group placing central venous 3 
lines for the hospital outside of a formal line team structure. Two of the participating hospitals 4 
had not developed or implemented a line team or designated a group to place lines, but had 5 
managed an iatrogenic complication related to central venous access in a patient with COVID-6 
19. Most of the hospitals that participated were urban, academic, university-affiliated hospitals 7 
with more than 400 beds (Table 1). Thirty-one of the hospitals had developed and implemented a 8 
central venous access line team specifically for the pandemic, while five hospitals had a plan for 9 
a line team but had not yet implemented it. Twenty-five of the participating hospitals had a 10 
physician group placing central venous lines as part of their routine clinical practice, without 11 
being designated as a “line team.” Eight of the hospitals that implemented a line team had a 12 
central venous access line team in existence prior to the pandemic, with four making no changes 13 
once the pandemic started. Two changed the PPE protocols for their line teams with the onset of 14 
the pandemic. One made services available on the weekends and ensured that attending 15 
physicians were physically present in the hospital at all times. One had a pre-existing medical 16 
proceduralist team which remained in place with the addition of a surgical team to supplement or 17 
take over their responsibilities when the medical specialists get called to take care of patients. 18 
             Central venous access line teams were most commonly composed of vascular and 19 
general surgery attending physicians and trainees, with some hospitals including attending 20 
physicians and trainees of other specialties such as interventional radiology and anesthesiology 21 
(Figure 1). Nearly all of the line teams were developed served or intended to serve patients who 22 
had tested positive for the SARS-CoV-2 virus (COVID-19+) in the intensive care unit setting 23 
15 
 
(ICU) (42, 96%) as well as patients under investigation for SARS-CoV-2 infection (COVID-1 
19PUI) in the ICU (40, 90%). Fewer line teams included patients who had tested negative for the 2 
SARS-CoV-2 virus (COVID-19-) in the ICU (28, 66%).  Most line teams also provided service 3 
for COVID-19+ and COVID-19PUI patients on the floor setting (28, 64%).  Some line teams 4 
provided services for COVID-19+ (25, 57%) and COVID-19PUI (22, 50%) patients in the 5 
emergency department. 6 
The plan to utilize the services of a central venous access line team during the pandemic 7 
was most commonly initiated by the vascular surgery division/department (15, 34%) or critical 8 
care team (11, 25%). The burden of COVID-19+ patients exceeding a critical threshold at the 9 
institution, where providers with training were present but overwhelmed, was cited as one of the 10 
reasons for implementing the line team by 22 (50%) of hospitals. The importance of minimizing 11 
line placement complications was cited as one of the reasons for implementation by 23 (52%) of 12 
hospitals. The majority of line teams made their services available daily at all hours (28, 64%), 13 
while at some hospitals (5, 12%), the timing of line team service availability varied by the phase 14 
of the pandemic and the stress on the resources in their hospital. These hospitals required 15 
exceeding a critical volume threshold for the central venous access line team to become 16 
activated. The criteria for terminating the line team services included a combination of: 1) 17 
reduction of hospitalized COVID patients to below a critical threshold (64%), 2) increased 18 
availability of other providers with line placement skills (25%), and 3) line team members 19 
returning to regular duties (41%). 20 
Central venous access line team characteristics 21 
16 
 
              In the 58 hospitals placing lines, six sites (10%), had no trainees involved in 1 
central venous line placement procedures. At eleven hospitals (19%), the attending physician 2 
was in the room during every line placement procedure. Of the 41 remaining hospitals, 30 had 3 
trainees that were at least at post-graduate year three level performing the central venous access 4 
procedures, with attending physicians immediately available.  5 
            Triple lumen catheters (TLCs), Cordis® catheters, non-tunneled hemodialysis catheters 6 
(NTHDCs) and tunneled hemodialysis catheters (THDCs) were the most common types of 7 
central venous lines placed (Figure 2).  Six of the hospitals also performed peripherally inserted 8 
central catheters (PICC); however, they reported that this practice was in place prior to the 9 
pandemic and remained unchanged. 10 
Among the 44 hospitals with line teams in place or planned, additional line team services 11 
provided, beyond central venous line placement during the COVID-19 pandemic, included: 12 
arterial line placement (82.8%), orogastric/nasogastric tube placement (18%), tube thoracostomy 13 
(16%), Foley catheter placement (10%), intubation (7%), tracheostomy (5%), gastric tube 14 
placement (2%), and rectal tube placement (2%). For the 31 hospitals with line teams in place, 15 
the reported numbers of central venous line placements performed over the seven days preceding 16 
participation in this study varied from <10 to >40, with the most common category being >40 17 
(Table 1). 18 
Anatomic considerations 19 
The internal jugular veins were the preferred sites for TLC and hemodialysis catheter 20 
(HDC) placement prior to the COVID-19 pandemic (Table 2); these continued to be the 21 
preferred sites during the pandemic for COVID-19+, COVID-19PUI and COVID-19- patients. 22 
17 
 
However, during the pandemic, the participating sites used the internal jugular and subclavian 1 
veins less frequently than prior to the pandemic, while the great saphenous (GSV) and popliteal 2 
veins (PV) were used more frequently. For supine COVID-19+ patients, the first choice for TLC 3 
placement was the right internal jugular vein in 31 (52.5%) hospitals and the left internal jugular 4 
vein in 22 (37.3%). The first-choice location for HDC placement was the right internal jugular 5 
vein in 46 (82.1%) of the hospitals. Similar patterns were found for COVID-19PUI (Table 2). 6 
Most participating sites considered similar anatomic locations for COVID-19+ and 7 
COVID-19- patients; however, 18 (30.5%) sites reported that their preferences for venous access 8 
in COVID-19+ patients were different from COVID-19- patients, with the most common reason 9 
being the ease of accessibility and the likelihood of kinking the catheters if the patient required 10 
prone positioning. Other considerations included the risk of pneumothorax and the proximity to 11 
the patient’s airway, potentially increasing the risk of infection to the providers performing the 12 
procedure. In addition, 16 (27%) sites considered renal failure or impending renal failure 13 
requiring dialysis as a factor in choosing anatomic location for TLCs or HDCs. Most reported 14 
preserving the right internal jugular vein for HDCs and avoiding the femoral veins for HDCs for 15 
potential prone positioning required for COVID-19 treatment. 16 
             Eight (14%) sites reported experience with placing central venous lines in prone, 17 
ventilated COVID-19+ patients, with no associated complications. Six of the sites always 18 
delayed line placement until the patient returned to the supine position, or they requested that the 19 
patient be returned to the supine position for the procedure. One site placed the lines with the 20 
patient remaining in the prone position. Two sites placed the line with the patient remaining in 21 
the prone position if they could safely access the vein laterally. In this population of patients who 22 
required prone positioning, TLCs continued to be placed in either the right or the left internal 23 
18 
 
jugular veins, the femoral vein, or the great saphenous vein. HDCs were placed exclusively in 1 
the right internal jugular vein.  Three lines were placed while the patient remained in the prone 2 
position: 1) a TLC placed in the popliteal vein, 2) a NTHDC placed in the right internal jugular 3 
vein, and 3) a TLC placed in the right internal jugular vein. Standard line placement techniques 4 
were used with ultrasound guidance and percutaneous Seldinger technique. 5 
             All 58 sites placing central venous lines during the COVID-19 pandemic used 6 
ultrasound guidance during line placement and nearly all participants (52, 90%) reported 7 
obtaining a chest X-ray (CXR) to confirm line placement for internal jugular or subclavian lines 8 
in COVID-19+ patients. Those who did not obtain a CXR acknowledged that this deviated from 9 
their normal practice. Their rationale for not utilizing a CXR was to limit exposure of hospital 10 
staff and radiology technologists, while conserving personal protective equipment (PPE).  11 
Supplies and PPE utilization 12 
             A dedicated line cart was used at 35 (59%) hospitals. The most common items 13 
stored in these line carts were: kits for TLCs, HDCs, Cordis® catheters (100%), sterile gloves 14 
(97%), sterile gowns (97%), sterile preparation sticks (94%), sterile gauze (94%), ultrasound 15 
probe covers (94%), selection of syringes (91%), sterile saline flushes (91%), sutures (91%), 16 
masks (91%), and bouffant hats (85%) (Appendix B). 17 
             PPE utilization patterns by line teams in COVID-19+ patients and COVID-19PUI 18 
were similar (Table 3). A small but significant number of line teams continued to use N95 masks 19 
with or without surgical masks, even in COVID-19- patients (Table 3).  When asked if hospitals 20 
experienced an increased incidence of needle sticks to providers associated with central line 21 
19 
 
placement during the COVID-19 pandemic, 28 (47%) responded “no” and 31 (52%) “did not 1 
know”. 2 
Prevention and management of thrombosed central lines 3 
              Less than 50% (24, 41%) of the participating sites in this study reported 4 
managing thrombosed central lines in COVID-19+ patients: 19 (33%) sites reported managing at 5 
least one thrombosed TLC, 21 (36%) HDC, and 2 (3%) Cordis® catheters. Over half of the sites 6 
(32, 54%) believed that central lines were more likely to thrombose in COVID-19+ patients, 7 
compared to COVID-19- patients, due to hypercoagulability. Most also believed that HDCs were 8 
more likely to thrombose in COVID-19+ patients than any other type of central venous lines. 9 
             Only 13 (22%) participating sites recommended varying types of routine 10 
anticoagulation in COVID-19+ patients to maintain central line patency, including: prophylactic 11 
dosing of unfractionated heparin (4 sites), therapeutic dosing of unfractionated heparin (1 site), 12 
prophylactic dosing of low molecular weight heparin (5 sites), and therapeutic dosing of low 13 
molecular heparin (2 sites).  The two remaining hospitals anticoagulated all COVID-19+ 14 
patients, regardless of whether the patient had a central venous access line in place. The majority 15 
of the participants who recommended anticoagulation were concerned about a high rate of 16 
thrombosis in COVID-19+ patients and recommended anticoagulation to minimize resource 17 
utilization.  18 
 Only 7 (12%) participating sites were routinely changing central lines. Of those 7 sites, 5 19 
reported that routine changing of lines was part of their regular practice, regardless of the 20 
pandemic. One site changed the line every three days, one every four days, four every seven days 21 
and one every eight days. 22 
20 
 
Complications and deaths 1 
 Twenty participating sites reported 2,657 lines placed by their designated group or line team 2 
in COVID-19+, COVIDPUI and/or COVID-19- patients; there were 11 (0.4%) iatrogenic 3 
complications associated with central venous access line placement procedures performed by the 4 
designated group or line team at those sites. These consisted of two inadvertent placements of a 5 
catheter into an artery, seven instances of hematoma or active bleeding at catheter sites, one 6 
instance of pneumothorax and one air embolism. The air embolism was in a COVID-19+ patient 7 
who was not intubated and the patient expired shortly thereafter. This was the only death directly 8 
related to an iatrogenic venous access complication. 9 
A total of 48 iatrogenic complications of central venous line placement in the COVID-10 
19+ population were managed by 23 (38%) participating sites, including complications 11 
associated with procedures performed by providers outside of their line team or designated 12 
group (Table 4). The most common type of complication was inadvertent placement of a catheter 13 
into an artery. In 20 of the complications, the participating site believed something could have 14 
been done differently during the initial access attempt to prevent the complication. In almost all 15 
of these cases, the participating site believed that a combination of a more experienced operator, 16 
meticulous use of ultrasound, and maintaining wire control at all times could have prevented the 17 
complication.  18 
With respect to the COVID-19+ population, in one case of inadvertent puncture of the 19 
artery, the wire was left in the femoral artery and the patient was anticoagulated, since the patient 20 
was deemed too unstable for intervention. In three of the cases of inadvertent placement of a 21 
catheter into an artery, the patient was deemed too unstable from COVID-19 to undergo an 22 
21 
 
intervention. In all but three of the complications in the COVID-19+ population, the participating 1 
sites indicated that they would have managed the iatrogenic complication in a COVID-19- 2 
patient in a similar manner to what was done in the COVID-19+ patient.  For three 3 
complications, the sites stated they may have considered more aggressive surgical or 4 
interventional management if the patient had not been COVID-19+.   5 
Discussion: 6 
We describe the formation, implementation and results of dedicated central venous access 7 
line teams led by physicians with central venous access expertise during the COVID-19 8 
pandemic. These dedicated line teams served as an invaluable resource in stressed health care 9 
systems. This is aptly demonstrated by the 2,657 lines placed by 20 of the line teams. Each of 10 
these lines represents an instance where the line team enabled the ICU team to focus on the care 11 
of an unprecedented high volume of critically ill patients, rather than spend time preparing for 12 
the procedure, donning and doffing PPE and performing the procedure. These line teams 13 
represent “bringing together elements to ensure an effective response”, which is a key point that 14 
is repeatedly emphasized in disaster management17.  15 
The rapid spread of the pandemic exposed a lack of disaster preparedness in hospitals 16 
worldwide18. Most healthcare disasters occur without notice19. In order to optimize outcomes 17 
during a disaster, plans for managing a disaster need to be in place prior17,19. The lessons learned 18 
from this initial line service experience can be readily applied to future healthcare crises and 19 
future surges of the COVID-19 pandemic. In fact, at the time of this writing (June 10, 2020), 20 
stay-at-home orders are being lifted across the US. Since the stay-at-home order was lifted in 21 
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Arizona on May 16, cases have increased by 108% in that state with an associated increase in 1 
hospitalizations and strain on the healthcare system20.  2 
Vascular surgeons are uniquely trained to lead dedicated central venous access line 3 
teams, since a vascular practice usually encompasses routine percutaneous arterial and venous 4 
access, invariably using ultrasound guidance. The technical skills necessary to perform a high 5 
volume of these procedures, with a low complication rate, are critical for these teams to be of 6 
value.  Based on the experiences of the participants in this study, we have identified a set of best 7 
practices for central venous line placement during times when hospital systems are stressed by 8 
disasters such as the COVID-19 pandemic. 9 
Standard Practices 10 
Line Team Implementation: Each institution should determine an appropriate schedule for 11 
line team activation, based on available resources and individual institutional needs. Ideally, the 12 
team should be available throughout the day, and any limitations should be communicated to the 13 
intensive care units and emergency rooms. The ramp-up and ramp-down of the line team should 14 
be individualized to the needs of the institution and the central venous access service line. A 15 
number of participants in this study highlighted the importance of understanding variations in 16 
individual institutional resource allocation, with this being a key to providing service at the 17 
optimal time and place. 18 
Line Cart: An adequately stocked line cart increases the efficiency of line placement 19 
procedures. This cart should have all the supplies and PPE necessary to safely perform central 20 
venous line placements and remain outside the room to reduce cross contamination. Having an 21 
appropriately stocked cart, as pointed out by a number of participants, reduces donning and 22 
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doffing of PPE, minimizes potential provider exposure, and allows for a more streamlined and 1 
efficient placement of venous access. Appendix C demonstrates equipment we recommend on a 2 
line cart, including PPE. 3 
PPE: It is paramount that proceduralists be provided with appropriate PPE. We found 4 
that the majority of our respondents were following best practices for PPE utilization – wearing 5 
an N95 mask, covered by a surgical mask, protective eye wear, bouffant/surgical cap, and a 6 
gown and gloves for COVID-19+ patients. A number of sites recommended that there should be 7 
no more than two providers in the room, with a “runner” outside the room, who can retrieve 8 
additional supplies as needed, in order to preserve PPE and minimize exposure. 9 
Location of Central Lines: The preferred location of central venous access lines was 10 
relatively consistent across respondents. Given the high incidence of acute renal failure and need 11 
for acute hemodialysis in the COVID-19+ population, most centers preferably placed central 12 
lines in the left internal jugular vein, reserving the right internal jugular vein for non-tunneled 13 
hemodialysis lines. Given the high rate of COVID-19+ ICU patients requiring prone positioning, 14 
femoral lines were avoided; several centers reported placing popliteal vein lines in these patients. 15 
Subclavian lines were also discouraged, given the known increased incidence of pneumothorax 16 
over internal jugular lines. Several centers used 55cm hemodialysis lines intended for tunneled 17 
placement, in a non-tunneled fashion when femoral dialysis access was needed. The cuff 18 
remained outside the patient, with the intent that the extra catheter length and stiffer catheter 19 




Ultrasound guidance: All centers utilized ultrasound guidance when performing central 1 
venous access. Notably, participating sites believed that over half of the iatrogenic complications 2 
they managed could have been prevented with meticulous use of ultrasound guidance. 3 
Ultrasound guidance has become the standard of care in placement of central lines and should 4 
continue to be used in disaster situations such as the COVID-19 pandemic, despite the additional 5 
time required to thoroughly clean the machine between uses21. Participants recommended 6 
confirming wire position in the long axis ultrasound view and using a sterile cover over the entire 7 
ultrasound probe and machine during the procedure to reduce the risk of cross-contamination. 8 
Wireless ultrasound transducers may be particularly useful in this clinical scenario(10). 9 
Post Placement Confirmation: In critically ill patients, reducing complications is 10 
paramount, and early identification of complications is a key to patient survival. Thus, obtaining 11 
a post-procedure chest X-ray to confirm the tip location and that no pneumothorax has occurred 12 
continues to be an important step used by the majority of hospitals, even in a limited resource 13 
situation. Careful examination of the images by the treating physician, to rule out pneumothorax, 14 
is of particular importance in intubated patients, especially with higher pressure ventilator 15 
settings. 16 
Needlestick Prevention: We were reassured to see that there was a low incidence of 17 
needlestick injuries. In stressful situations, it is important to continue to practice safely, 18 
particularly with sharps and sharps disposal. Stressful and unfamiliar working conditions, lack of 19 
adequate protective medical/technical equipment and poor work routines are known to contribute 20 
to needlestick injuries22. Using an experienced, well-prepared team allows for the repetition and 21 
expertise needed to reduce needle stick injuries. During this particular pandemic, patients that are 22 
COVID-19+ or COVID-19PUI must both be handled with the same care, caution, and PPE. 23 
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Management of Hypercoagulability and Line Thrombosis: Hypercoagulability in the 1 
COVID-19+ population is well established23-25. We found variability among hospitals in 2 
reporting their experience with thrombosed central lines; consequently, prevention strategies also 3 
differed. The majority of thrombosed lines were NTHDC, and the thrombosis presumably 4 
occurred during continuous veno-venous hemofiltration, a known complication of a low flow 5 
hemodialysis session26. However, we were surprised to find the large number of TLCs that also 6 
thrombosed. Some participants recommended running continuous infusions of low-dose 7 
heparinized saline through any lines that are not being used for other infusions. 8 
Complications: Complications secondary to central venous line placement are always 9 
expected; however, the overall complication rate of 0.4% when central venous lines are placed 10 
by dedicated line teams is significantly lower than the rate of up to 15% that has been previously 11 
published27-28. The incidence of arterial cannulation during central venous access has been 12 
reported to be in the range of 4.2%-9.3% of all line placements29. In a study of 539 central 13 
venous catheter placements under ultrasound and fluoroscopy guidance, 486 of the lines were 14 
primarily placed by a surgical trainee30. The associated complication rate was 8.4%, 93% of 15 
which were arterial punctures. This suggests a dedicated line team may not only increase 16 
efficiency of provider utilization in a pandemic but may also reduce complications in a fragile at-17 
risk population.  18 
Limitations 19 
As with all studies using retrospective, self-reported data, there is a possibility of 20 
reporting error or inaccuracy. To minimize this risk we standardized the data points with specific 21 
definitions and carefully reviewed the submitted data to identify any discrepancies. All 22 
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discrepancies were clarified individually with the participating investigator. Our study would be 1 
strengthened by a matched contemporaneous comparison group of hospitals that did not 2 
implement a central venous access line team or designate a group to place lines. Another 3 
valuable comparison would be the rate of complications at participating hospitals before the 4 
pandemic. However, these types of studies require a complex study design with recruitment of 5 
matched hospitals and abstraction of data that was not readily available during the pandemic.  6 
This was not feasible at the time of the study, but could be performed in the future to quantify the 7 
impact of line teams on the incidence of iatrogenic central venous access complications. Lacking 8 
this, we relied on historical data in the literature for iatrogenic complication rates of central 9 
venous line procedures and anatomical preferences for central venous line placement.  10 
This data was collected at the height of the pandemic for many participating institutions. 11 
As such, we sought to describe practice patterns that could possibly be useful to other institutions 12 
in preparing for future waves of the pandemic or other health care crises, using data that was 13 
easily accessible to participating institutions during the potentially chaotic time. This study 14 
serves as a hypothesis-generating study that brings up several granular issues relevant to the 15 
effectiveness of line teams, requiring more laborious data extraction that should be investigated 16 
in the future. A study examining the cost effectiveness of maintaining a line cart and dedicating 17 
personnel to line teams, balanced against the potential decrease in procedural complications and 18 
increased efficiency, would provide insight into the financial burden of implementing this 19 
intervention. Comparing the degree of change in volume of central line placements before the 20 
pandemic to during the pandemic, when the line teams were in place, would quantify the 21 
magnitude of the line placement challenge.  22 
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The unit of analysis in this study was the hospital. Patient-specific data were collected 1 
only in the case of complications and line placement in prone patients. Future studies utilizing 2 
patient-specific data addressing issues such as whether the rates of line sepsis were influenced by 3 
the pandemic would provide further insight into the impact of the pandemic on management of 4 
central venous access.  5 
As physicians learn more about managing patients with COVID-19, practice patterns may 6 
change with regard to line team structure and function, preferred anatomic locations and other 7 
technical issues. A follow-up study in the future regarding “lessons learned” from central venous 8 
access during the pandemic and the associated changes in practice patterns in response would be 9 
valuable. 10 
Conclusion: 11 
The implementation of a dedicated central venous access line team is a way in which 12 
physicians trained in percutaneous central venous access can make a contribution to a stressed 13 
healthcare system during a pandemic or other healthcare crisis. A line team composed of 14 
physicians with vascular skill sets provides relief to resource-constrained ICU, ward, and 15 
emergency medicine teams with a low rate of iatrogenic complications relative to historical 16 
reports. We recommend that a plan for central venous access line team implementation be in 17 
place for future healthcare emergencies; including staffing, a dedicated line cart, 18 
recommendations on the optimal anatomic site and technique, as well as a method to track 19 
complications. 20 
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Table 1. Hospital characteristics and central venous line placement volume 
 
 Hospitals with line team in 
place or planned 
n=44 (%) 
Groups placing lines at their 




     Urban 
     Academic university 
affiliated 
     Non-university affiliated 
teaching 
     Community/private 
     Public 















Hospital size by baseline beds 
     100-199 
     200-299 
     300-399 















Line placements in previous 7 
days*   
     0-10 
     10-20 
     20-30 
     30-40 












*Line placements in the 7 days preceding data entry into the study  
Table 2. Anatomic preferences for central venous catheter placements by COVID-19 status  
 

















       
     Prior to 
Pandemic 
59 (97) 58 (95) 41 (67) 39 (64) 52 (85) 2 (3) 0 (0) 
     COVID-19+ 52 (85) 50 (82) 27 (44) 26 (43) 48 (79) 4 (7) 2 (3) 
     COVID-19PUI 55 (90) 51 (84) 27 (44) 27 (44) 49 (80) 4 (7) 1 (2) 
     COVID-19- 59 (97) 58 (95) 34 (56) 32 (53) 49 (80) 2 (3) 0 (0) 
        
1
st
 choice for supine 
patient 
       
     COVID-19+        
         TLC 31 (53) 22 (37) 2 (3) 0 (0) 4 (7) 0 (0) 0 (0) 
         HDC  46 (82) 0 (0) 2 (3) 0 (0) 8 (14) 0 (0) 0 (0) 
     COVID-19PUI        
          TLC 30 (51) 23 (39) 2 (3) 0 (0) 4 (7) 0 (0) 0 (0) 
          HDC 45 (80) 0 (0) 2 (3) 0 (0) 9 (16) 0 (0) 0 (0) 
R IJ: right internal jugular vein; L IJ: left internal jugular vein; R SC: right subclavian vein; L SC: 
left subclavian vein; Fem: femoral vein; GSV: greater saphenous vein; Pop: popliteal vein; 
COVID-19+: patient who has tested positive for SARS-CoV-2 virus; COVID-19PUI: patient under 
investigation for SARS-CoV-2 infection; COVID-19-: patient who has not tested positive for 






Table 3. Personal protective equipment used during placement of central venous lines 
populations by COVID-19 status 
 COVID-19+ (%) COVID-19PUI 
(%) 
COVID-19- (%) 
Surgical mask without N95 1 (2) 2 (3) 41 (67) 
N95 without surgical mask 15 (25) 13 (21) 6 (10) 
N95 with surgical mask over 45 (74) 46 (75) 12 (20) 
Powered air-purifying 
respirator  
10 (16) 8 (13) 2 (3) 
Face shield 54 (89) 55 (90) 36 (59) 
Gown 55 (90) 54 (89) 55 (90) 
Bunny suit with hood 5 (8) 4 (7) 0 (0) 
Bunny suit without hood 3 (5) 3 (5) 0 (0) 
Bouffant/surgical cap 52 (85) 52 (85) 48 (79) 
Goggles 2 (3) 1 (2) 0 (0) 
COVID-19+: patient who has tested positive for SARS-CoV-2 virus; COVID-19PUI: patient under 
investigation for SARS-CoV-2 infection; COVID-19-: patient who has not tested positive for SARS-
CoV-2 virus 
 
Table 4. Iatrogenic complications of central venous line placement in COVID-19+ patients managed by participating sites.  
 








IJ / Carotid SC Fem Other Initial Management Strategy Initial Management 
Success 
Inadvertent arterial 
puncture with wire in 
place prior to 
catheter placement 
3  0 2 0 1  Pull line and hold pressure (1)  






puncture with dilator 
in place prior to 
catheter placement 
2 0 1 0 0 Descending 
aorta 
Pull line and hold pressure (1), 






remaining in artery 
16 1 5 6 4 Brachio-
cephalic 
artery 
Pull line and hold pressure (5), 
Endovascular mgmt w balloon (2), 
Closure device (1), 
Endovascular mgmt w stent graft (1), 
Open surgical repair (3), 










puncture with no 
catheter remaining in 
artery but active 
extravasation 
present 
2  0 0 1 1  Pull line and hold pressure (2) Yes 
Catheter or wire 
fracture/embolizatio
n 
3  0 0 0 1 aorta 
right atrium 
 





Hematoma or active 
bleeding at catheter 
site with catheter in 
place and catheter in 





Pneumothorax 11 1 4 5 0 2 unknown Tube thoracostomy (11) Yes 
Air embolism 1 1 1 0 0 None attempted No 
*see text; IJ: internal jugular, SC: subclavian, fem: femoral
Figure 1. 
















TLC: triple lumen catheter; NTHDC: non-tunneled hemodialysis catheter; THDC: tunneled 
hemodialysis catheter; VV ECMO: veno-venous extracorporeal membrane oxygenation; AV 
ECMO: arterio-venous extracorporeal membrane oxygenation; PD: peritoneal dialysis; PICC: 
peripherally inserted central catheter; Others include: Infusaports, Hickman catheters and small 
bore sheaths for potential ECMO candidates 
 
Types of Central Venous Lines



































Figure 1. Central Venous Access Line Team Composition. VS: Vascular Surgery; GS: General 
Surgery: IR: Interventional Radiology; Card: Cardiology; CTS: Cardiothoracic Surgery; Med: 
Medicine; Anes: Anesthesia. 
*Percentage of Line Teams that Include Attending Physicians and Trainees of Each Specialty 
 
 
Figure 2. Types of central venous lines placed by line teams (n=44). TLC: triple lumen catheter; 
NTHDC: non-tunneled hemodialysis catheter; THDC: tunneled hemodialysis catheter; VV 
ECMO: veno-venous extracorporeal membrane oxygenation; AV ECMO: arterio-venous 
extracorporeal membrane oxygenation; PD: peritoneal dialysis; PICC: peripherally inserted 
central catheter; Others include: Infusaports, Hickman catheters and small bore sheaths for 
potential ECMO candidates 
 
Table 1. Hospital characteristics and central venous line placement volume. *Line placements in 
the 7 days preceding data entry into the study 
 
Table 2. Anatomic preferences for central venous catheter placements by COVID-19 status. R 
IJ: right internal jugular vein; L IJ: left internal jugular vein; R SC: right subclavian vein; L SC: 
left subclavian vein; Fem: femoral vein; GSV: greater saphenous vein; Pop: popliteal vein; 
COVID-19+: patient who has tested positive for SARS-CoV-2 virus; COVID-19PUI: patient 
under investigation for SARS-CoV-2 infection; COVID-19-: patient who has not tested positive 
for SARS-CoV-2 virus; TLC: triple lumen catheter; HDC: hemodialysis catheter 
 
Table 3. Personal protective equipment used during placement of central venous lines 
populations by COVID-19 status. COVID-19+: patient who has tested positive for SARS-CoV-2 
virus; COVID-19PUI: patient under investigation for SARS-CoV-2 infection; COVID-19-: 
patient who has not tested positive for SARS-CoV-2 virus 
 
Table 4. Iatrogenic complications of central venous line placement in COVID-19+ patients 
managed by participating sites. *see text; IJ: internal jugular, SC: subclavian, fem: femoral 
 
Appendix A. Hospitals represented in this study. 
 
Appendix B: Items placed on dedicated line carts used by line teams. 
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Canada  Vancouver General Hospital 
France  Ambroise Paré University Hospital, AP-HP 
Germany  University Medical Center Hamburg-Eppendorf 
Greece  General Hospital of Athens KAT 
India  Medanta Hospital 
  Postgraduate Institute of Medical Education and Research 
Italy  Policlinico Gaetano Martino 
Korea (South)  Kyung Hee University Hospital at Gangdong 
Mexico  Instituto Nacional de Ciencias Médicas y Nutrición Salvador 
Zubirán 
New Zealand  Waikato Hospital 
Singapore  National University Hospital 
Sri Lanka  National Institute of Nephrology Dialysis and Transplantation 
Switzerland  University Hospital Zurich 
 AZ Banner University Medical Center-Tucson 
 AZ Mayo Clinic Hospital 
 CA Community Regional Medical Center 
 CA Olive View- UCLA Medical Center 
 CA Palo Alto Veterans Affairs Medical Center 
 CA Ronald Reagan UCLA Medical Center 
 CA  Veterans Affairs Greater Los Angeles 
 CO Rocky Mountain Regional Veterans Affairs Medical Center 
 CO Rose Medical Center 
 CO University of Colorado Anschutz Medical Campus 
 IA University of Iowa Hospitals and Clinics 
 IL Loyola University Medical Center 
 IL NorthShore University Health System 
 IL Northwestern Memorial Hospital 
 IN Eskenazi Health 
 IN Indiana University Health Methodist Hospital 
 IN Indiana University Health North Hospital 
 IN Indiana University Health West Hospital 
 LA Our Lady of the Lake 
 LA West Jefferson Medical Center 
 MA Boston Medical Center 
 MA Massachusetts General Hospital 
 MA University of Massachusetts Medical Center 
 MD The Johns Hopkins Hospital 
 MI Henry Ford Hospital 
 MI McLaren Bay Region 
 MI McLaren Flint 
 MO St. Louis University Hospital 
 NJ Overlook Medical Center 
 NJ Rutgers Robert Wood Johnson University Hospital 
 NJ University Hospital 
 NY Jacobi Medical Center 
 NY Montefiore Medical Center 
 NY Mount Sinai Brooklyn 
 NY The Mount Sinai Hospital 
 NY Mount Sinai Queens 
 NY New York-Presbyterian Columbia University Medical Center 
 NY New York- Presbyterian Queens 
 NY North Shore University Hospital, Northwell Health 
 NY  Weill Cornell Medicine 
 TX Audie L Murphy Veterans Affairs Hospital 
 TX Dallas Veterans Affairs Medical Center 
 TX Memorial Hermann-Texas Medical Center 
 TX University of Texas Health Science Center at San Antonio 
University Hospital  
 UT University of Utah Hospital 
 VA Virginia Commonwealth University Medical Center 





Appendix B: Items placed on dedicated line carts used by line teams. 
 
Item (%) 
Central line kits 100 
Sterile gloves 97.1 
Sterile gowns 97.1 
Sterile preparation sticks 94.3 
Sterile gauze 94.3 
Ultrasound probe cover 94.3 
Selection of syringes 91.4 
Sterile saline flush 91.4 
Sutures 91.4 
Masks 91.4 
Bouffant hats 85.7 
Selection of hypodermic needles 80.0 
Surgical towels 80.0 
Tape 77.1 
Selection of sterile drapes 77.1 
Face shields 77.1 
Lidocaine 74.3 
Micropuncture sets 74.3 
3-way stopcock 71.4 
Antimicrobial dressing 71.4 
  




Bouffant head covering 








Central Line Kits 
Non-tunneled hemodialysis access kits 
Arterial line kits (Arrow, micropuncture) 
12” extension tubing 
Surgical towels 
Drapes: for arterial lines, central lines 
Sterile gloves 
Sterile gowns 
Sterile preparation sticks 
Sterile gauze 
Selection of syringes 
Selection of hypodermic needles 
Suture 
Ultrasound probe cover 
Lidocaine 
3-way stopcock 
Antimicrobial dressing 
 
 
